Comparative analysis of axial length measurement method for eyes with submacular hemorrhage
- PMID: 39832021
- DOI: 10.1007/s10384-024-01147-2
Comparative analysis of axial length measurement method for eyes with submacular hemorrhage
Abstract
Purpose: To identify a method for comparing preoperative axial length (AL) measurements with postoperative AL in submacular hemorrhage (SMH).
Study design: Retrospective.
Methods: This study included 30 patients who underwent vitrectomy for SMH (January 2016-January 2023) with preoperative and postoperative AL data. Preoperative AL was obtained using ultrasonography for the affected eye (aUS-AL) and compared to those measured using optical biometry (OB) for the affected and fellow eyes (aOB-AL and fOB-AL, respectively). Postoperative AL (aPost-AL) was defined as the AL of the affected eye by OB. The absolute differences between the preoperative AL (aUS-AL, aOB-AL, and fOB-AL) and aPost-AL were assessed.
Results: aUS-AL, aOB-AL, and fOB-AL values were 23.50 ± 1.41 mm, 23.32 ± 1.40 mm, and 23.66 ± 1.45 mm, respectively, correlating strongly with aPost-AL (23.54 ± 1.37 mm) (all R > 0.95). fOB-AL exceeded aPost-AL significantly (P = 0.02). In all 30 eyes, absolute differences between preoperative AL and aPost-AL were 0.19 ± 0.18 mm, 0.28 ± 0.32 mm, and 0.21 ± 0.22 mm, respectively, which were not significantly different from each other (all P > 0.05). In nine eyes with SMH height > 1000 μm or unmeasurable, the absolute difference between aOB-AL and aPost-AL (0.42 ± 0.33 mm) exceeded that of aUS-AL and aPost-AL (0.10 ± 0.09 mm) (P = 0.003).
Conclusion: Although aUS-AL, aOB-AL, and fOB-AL correlated well with postoperative AL in patients with SMH, fOB-AL may be measured longer and aOB-AL shorter in some cases. Therefore, aUS-AL may be considered primarily in determining IOL power of cataract surgery performed in combination with SMH displacement.
Keywords: Axial length measurement; Optical biometry; Refractive error; Submacular hemorrhage; Vitrectomy.
© 2024. Japanese Ophthalmological Society.
Conflict of interest statement
Declarations. Conflict of interest: M. Nagayama, None; S. Kimura, None; M. Morizane Hosokawa, None; Y. Shiode, None; R. Matoba, None; T. Morita, None; K. Kanenaga, None; Y. Morizane, None.
References
-
- Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33–7. - PubMed
-
- Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213:97–102. - PubMed
-
- Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Toth CA, Fekrat S, et al. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. Am J Ophthalmol. 2001;131:208–15. - PubMed
-
- Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirataka A. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm. Graefes Arch Clin Exp Ophthalmol. 2015;253:1663–9. - PubMed
-
- Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S et al. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator. Am J Ophthalmol. 2015;159:683-9.e1.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
